Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease
The popPK analysis suggested that faricimab dosing frequency was influenced by several factors and not by VH t1/2 alone.
Authors
- Katrijn Bogman (ORCID: https://orcid.org/0000-0003-2191-4461)
- Ekaterina Gibiansky
- Cheikh Diack (ORCID: https://orcid.org/0000-0002-6320-7522)
- Félix Jaminion
- Leonid Gibiansky (ORCID: https://orcid.org/0000-0001-6005-7760)
- Valérie Cosson
- Jacques Gaudreault
Institutions
- Roche (Switzerland) (CH)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1167/tvst.13.11.14
- Citations
- 7
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.77
Funders
- F. Hoffmann-La Roche